Prescription drug prices in the U.S. receive a lot of attention. Some of it is academic, such as comparisons amongst how we measure drug price trends or determine a drug’s price within a country. Other times, interest in drug pricing arises out of efforts to report newsworthy events, such as the implementation of drug price negotiation (or price setting, depending on your perspective) within the Inflation Reduction Act or to identify that a newly launched medication overtakes the previous as the most expensive medication ever to hit U.S. pharmacy shelves. Undoubtedly, 46brooklyn would itself not exist but for the interest that exists within societal efforts to understand drug prices. And yet, for all the attention drug prices receive, there appears to be a great deal that we don’t know about drug prices within the United States.
Of course, just the mere idea that there is so much effort invested in order to understand drug pricing suggests that the default premise that drug pricing is not understood.
Comments